Jeff Garro
Stock Analyst at Stephens & Co.
(0.52)
# 2,946
Out of 4,413 analysts
38
Total ratings
13.79%
Success rate
-17.22%
Average return
Main Sectors:
13 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHR Phreesia | Reiterates: Overweight | $28 | $20.74 | +35.00% | 7 | Mar 22, 2024 | |
| MDRX Veradigm | Reiterates: Equal-Weight | $13 | $7.99 | +62.70% | 6 | Nov 14, 2023 | |
| CERT Certara | Reiterates: Overweight | $20 | $17.11 | +16.89% | 4 | Oct 11, 2023 | |
| ACCD Accolade | Reiterates: Overweight | $18 | $7.63 | +135.91% | 5 | Oct 5, 2023 | |
| TDOC Teladoc Health | Reiterates: Equal-Weight | $28 | $12.75 | +119.61% | 2 | Jul 26, 2023 | |
| EVH Evolent Health | Reiterates: Overweight | $40 | $27.74 | +44.20% | 2 | May 4, 2023 | |
| RCM R1 RCM | Initiates: Overweight | $18 | $12.29 | +46.46% | 1 | Apr 12, 2023 | |
| PRVA Privia Health Group | Initiates: Overweight | $33 | $18.40 | +79.35% | 1 | Apr 12, 2023 | |
| OPRX OptimizeRx | Maintains: Neutral | $29 → $16 | $10.20 | +56.86% | 2 | Aug 10, 2022 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $15 → $20 | $5.15 | +288.35% | 3 | Aug 5, 2022 | |
| INNV InnovAge Holding | Maintains: Underweight | $5 → $3.9 | $3.55 | +9.86% | 2 | May 11, 2022 | |
| SLQT SelectQuote | Maintains: Neutral | $4 → $3 | $1.51 | +98.68% | 2 | May 6, 2022 | |
| IQV IQVIA Holdings | Upgrades: Overweight | $231 → $255 | $231.77 | +10.02% | 1 | Apr 29, 2022 |
Phreesia
Mar 22, 2024
Reiterates: Overweight
Price Target: $28
Current: $20.74
Upside: +35.00%
Veradigm
Nov 14, 2023
Reiterates: Equal-Weight
Price Target: $13
Current: $7.99
Upside: +62.70%
Certara
Oct 11, 2023
Reiterates: Overweight
Price Target: $20
Current: $17.11
Upside: +16.89%
Accolade
Oct 5, 2023
Reiterates: Overweight
Price Target: $18
Current: $7.63
Upside: +135.91%
Teladoc Health
Jul 26, 2023
Reiterates: Equal-Weight
Price Target: $28
Current: $12.75
Upside: +119.61%
Evolent Health
May 4, 2023
Reiterates: Overweight
Price Target: $40
Current: $27.74
Upside: +44.20%
R1 RCM
Apr 12, 2023
Initiates: Overweight
Price Target: $18
Current: $12.29
Upside: +46.46%
Privia Health Group
Apr 12, 2023
Initiates: Overweight
Price Target: $33
Current: $18.40
Upside: +79.35%
OptimizeRx
Aug 10, 2022
Maintains: Neutral
Price Target: $29 → $16
Current: $10.20
Upside: +56.86%
Alignment Healthcare
Aug 5, 2022
Maintains: Overweight
Price Target: $15 → $20
Current: $5.15
Upside: +288.35%
InnovAge Holding
May 11, 2022
Maintains: Underweight
Price Target: $5 → $3.9
Current: $3.55
Upside: +9.86%
SelectQuote
May 6, 2022
Maintains: Neutral
Price Target: $4 → $3
Current: $1.51
Upside: +98.68%
IQVIA Holdings
Apr 29, 2022
Upgrades: Overweight
Price Target: $231 → $255
Current: $231.77
Upside: +10.02%